Gene: CCDC127
Official Full Name: coiled-coil domain containing 127provided by HGNC
Gene Summary: Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26468 | CCDC127 Knockout cell line (HeLa) | Human | CCDC127 | 1:3~1:6 | Negative | Online Inquiry |
KO26469 | CCDC127 Knockout cell line (HCT 116) | Human | CCDC127 | 1:2~1:4 | Negative | Online Inquiry |
KO26470 | CCDC127 Knockout cell line (HEK293) | Human | CCDC127 | 1:3~1:6 | Negative | Online Inquiry |
KO26471 | CCDC127 Knockout cell line (A549) | Human | CCDC127 | 1:3~1:4 | Negative | Online Inquiry |
CCDC127 Gene Knockout Cell Lines are expertly engineered cellular models designed to study the function of the CCDC127 gene, which has been implicated in critical cellular processes such as the regulation of cell division and intracellular transport. These cell lines have undergone precise genome editing techniques, specifically CRISPR-Cas9 technology, to create targeted knockout mutations that help elucidate the gene's role in various biological phenomena.
The key function of CCDC127 Gene Knockout Cell Lines lies in their ability to facilitate the investigation of gene function by providing a platform to study phenotypic changes in the absence of the CCDC127 gene. Researchers can employ these cell lines to assess altered pathways, identify downstream effectors, and examine cellular responses to stressors or drugs. This mechanistic approach is vital in understanding the gene's contribution to diseases, including cancer and other genetic disorders.
The scientific importance of these cell lines extends to both basic research and clinical applications. In research settings, they enable the unraveling of molecular mechanisms underlying diseases, while in translational medicine, they can serve as a basis for drug discovery, providing insight into potential therapeutic targets. Their use can significantly streamline the process of validating hypotheses related to CCDC127, making them an indispensable tool in modern biological research.
Compared to traditional gene knockout methods or unmodified cell lines, our CCDC127 Gene Knockout Cell Lines offer higher specificity and efficiency. They allow for reproducible results, reducing variability that often arises in experimental systems. Additionally, the wider consensus around CRISPR technology ensures researchers have confidence in the consistency and reliability of these models.
For researchers and clinicians focused on genetic and cellular pathways, our product stands out as a critical resource for advancing knowledge and developing new therapeutic strategies. The value of our CCDC127 Gene Knockout Cell Lines is further enhanced by our company’s commitment to quality and innovation in the field of biological products, driven by a team of experts dedicated to supporting scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.